Tag: our research

Co-funded by us, Children with Cancer UK and Action Medical Research, the study from the University of Birmingham is the first of its kind.

New diagnostic techniques are driving real change in treatments for childhood brain tumours, a study reveals.

Our community have come together to share their stories and their wishes for our Winter Appeal, creating a powerful campaign.

Reported in The Times this morning, thousands have benefited over the last ten years due to surgical improvements.

Reported at this week’s The National Cancer Research Institute (NCRI) conference, the innovative test could change the way brain tumours are diagnosed earlier.

Researchers have developed a blood test that could help identify people with a brain tumour, even if they have no clear-cut symptoms.

A study released this morning revealed that too few children are receiving targeted drugs for their cancers

Tocagen, an American gene-therapy company, announced the trial’s failure yesterday.

This morning saw the release of the annual results from the English National Cancer Patient Experience Survey for 2018.

New findings out of the University of Sussex could be paving the way to a new test for glioblastoma (GBM) using only fluids, like blood or cerebrospinal fluid.

Dr Martina Finetti tells us about her background and her research into rare childhood brain tumours.

We have recently announced we will funding a study that looks at whether a therapy called Acceptance and Commitment Therapy (ACT) can be adapted to help treat young brain tumour survivors.

The Brain Tumour Charity are excited to announce that we will be funding a study exploring whether a psychological therapy called Acceptance and Commitment Therapy (ACT) can be adapted to help treat young brain tumour survivors.

A report published today into the use of medicinal cannabis for problems such as nausea caused by chemotherapy says patients have had their expectations raised unfairly by a change in the law last year

Our funded research has created a tool to help clinicians predict meningioma recurrence

Scottish scientist set to receive over £6 million from Cancer Research UK and The Brain Tumour Charity to find new ways to treat glioblastoma, one of the hardest types of cancer to treat.

Thanks to the support of our community, we’re pledging more than £3.7m to UK and international teams working towards our twin goals: doubling brain tumour survival and halving the harm caused by the disease

A research team from Germany has used artificial intelligence to improve the assessment of treatment response in brain tumours

As part of our commitment to increasing survival and halving the harm of brain tumours, we have committed over £1 million to transformative research

Thanks to your continued support and fundraising, we’re delighted to announce that we’ve been able to award over £3.8 million to five new exciting research initiatives across the globe

Dr Thomas Ward, part of the Leeds Institute of Cancer and Pathology research team, is funded by various cancer charities including The Brain Tumour Charity.

Dr Paul Brennan, from the University of Edinburgh, shares a round-up of his research with us.

In order to ensure that we fund only the highest quality research, we have formed two Scientific Advisory Boards (SABs) which are made up of internationally renowned scientific and medical experts that work in different areas of cancer research and social science.

Today we’re proud to announce a package of research initiatives totalling £4.3m.